ライフサイエンスコーパス: enzyme immunoassay

1 measles immunoglobulin G (IgG) serostatus by enzyme immunoassay.

2 , 18% (78/436) by PCR, and 22.2% (98/442) by enzyme immunoassay.

3 levels were quantified by using fluorescence enzyme immunoassay.

4 s were tested using a commercial measles IgM enzyme immunoassay.

5 Intracellular cAMP levels were measured by enzyme immunoassay.

6 using the MVista anti-Coccidioides antibody enzyme immunoassay.

7 rotavirus was detected in fecal specimens by enzyme immunoassay.

8 cGMP was assayed by an enzyme immunoassay.

9 eactive IgG for all five GI VLPs measured by enzyme immunoassay.

10 nd the C3 split product iC3b was measured by enzyme immunoassay.

11 d transformed human TM cells, as measured by enzyme immunoassay.

12 HSV-2 serostatus at baseline using an HSV-2 enzyme immunoassay.

13 ontent in the chamber tissue was measured by enzyme immunoassay.

14 ase chain reaction, immunohistochemistry, or enzyme immunoassay.

15 Histamine and leptin levels were measured by enzyme immunoassay.

16 and we measured products of C3 activation by enzyme immunoassay.

17 ected genes by reverse transcription-PCR and enzyme immunoassay.

18 Synovial levels of PBEF were quantified by enzyme immunoassay.

19 tides had been evaluated previously in a DNA enzyme immunoassay.

20 s from 514 mice were found to be positive by enzyme immunoassay.

21 and prolactin was measured by microparticle enzyme immunoassay.

22 s measured using a high-sensitivity sandwich enzyme immunoassay.

23 stools collected and tested for rotavirus by enzyme immunoassay.

24 olecule-1 concentrations were measured using enzyme immunoassay.

25 and prostaglandin E2), and interleukin-8 by enzyme immunoassay.

26 n cobalt binding (ACB) test and plasma iP by enzyme immunoassay.

27 cAMP in cultured cells was measured using an enzyme immunoassay.

28 PGE(2) levels were assessed by enzyme immunoassay.

29 anosine monophosphate (cGMP) was measured by enzyme immunoassay.

30 -beta1 and other cytokines was quantified by enzyme immunoassay.

31 ses) or negative (controls) for rotavirus by enzyme immunoassay.

32 a seroprotection and mumps seropositivity by enzyme immunoassay.

33 ermined through the limiting antigen avidity enzyme immunoassay.

34 nked immunosorbent assay and the competitive enzyme immunoassay.

35 24 and 48 hours were measured by commercial enzyme immunoassay.

36 tibodies against EBV viral capsid antigen by enzyme immunoassay.

37 e concentrations were quantified by using an enzyme immunoassay.

38 TIMP-2 were quantified by protein assay and enzyme immunoassay.

39 RT-PCR, quantitative immunofluorescence, and enzyme immunoassay.

40 8) and lactoferrin protein concentrations by enzyme immunoassay.

41 arable to that of both PCR and galactomannan enzyme immunoassay.

42 ibody to HBsAg (anti-HBs) and anti-HBc using enzyme immunoassay.

43 nd sera for antirotavirus immunoglobulins by enzyme immunoassays.

44 assessed at baseline and during follow-up by enzyme immunoassays.

45 s and testing HIV-positive on less sensitive enzyme immunoassays.

46 test and a range of agglutination assays and enzyme immunoassays.

47 ibition assay, complement fixation assay, or enzyme immunoassays.

48 ed herpes simplex virus type 1 type-specific enzyme immunoassays.

49 e, by Beadlyte technology (Luminex((R))) and enzyme immunoassays.

50 vors with HCV confirmed by second-generation enzyme immunoassay, 122 consented to participate in the

51 e tested for HHV-8 antibodies with use of an enzyme immunoassay against K8.1.

52 laboratory for KSHV antibodies with use of 2 enzyme immunoassays (against K8.1 and ORF65) and 1 immun

53 Enzyme immunoassay analysis showed that PGE2 release was

54 tudies have reported that galactomannan (GM) enzyme immunoassay and 1,3 beta-glucan (BG) assay may be

55 Enzyme immunoassay and a cytokine bead assay were used t

56 id and PF4/aptamer complexes, as shown by an enzyme immunoassay and a functional platelet activation

57 SV40 antibodies using a virus-like particle enzyme immunoassay and a plaque neutralization assay.

58 lutamate dehydrogenase and toxins A and B by enzyme immunoassay and cell culture cytotoxicity assay (

59 nti-inflammatory mediators using competitive enzyme immunoassay and enzyme-linked immunosorbent assay

60 Stool specimens were tested for rotavirus by enzyme immunoassay and genotyped, and rotavirus vaccinat

61 Fecal specimens were tested for rotavirus by enzyme immunoassay and genotyped.

62 Fecal specimens were tested for rotavirus by enzyme immunoassay and genotyped.

63 ed to results obtained retrospectively using enzyme immunoassay and nucleic acid amplification tests

64 y identified 230 HCV-infected patients using enzyme immunoassay and nucleic acid testing obtained dur

65 repeat testing for Clostridium difficile by enzyme immunoassay and PCR (i.e., initial negative resul

66 Measurements included third-generation HCV enzyme immunoassay and routine laboratory measurements.

67 rmance of standard HIV antibody tests (i.e., enzyme immunoassay and Western blot analysis) with an al

68 exogenously added peptide were evaluated by enzyme immunoassay and Western blotting, respectively.

69 e binding of monoclonal antibodies to LOS by enzyme immunoassay and Western blotting.

70 and 60 normal controls were examined both by enzyme immunoassays and by Western immunoblotting for au

71 nsuming and requires considerable expertise; enzyme immunoassays and direct fluorescent-antibody (DFA

72 ple purified allergens that could be used in enzyme immunoassays and in multiplex arrays for the stan

73 ples were tested for measles IgM antibody by enzyme immunoassays and plaque reduction neutralization

74 and tissue trophic factors were measured by enzyme immunoassays and quantitative RT-PCR.

75 een testing HIV-positive on highly sensitive enzyme immunoassays and testing HIV-positive on less sen

76 d affect the detection of p24 capsid by both enzyme immunoassays and Western blots.

77 ve to nucleic acid amplification test and/or enzyme immunoassay, and determined the delay in OFOQ con

78 PCR, lateral-flow diagnostics, plate-reader enzyme immunoassay, and direct tissue culture cytotoxici

79 ) were positive for human lymphotropic virus enzyme immunoassay, and none of 2,831 were positive for

80 road range of enteropathogens using culture, enzyme immunoassay, and PCR.

81 PCR, the production of resolvin D1 (RvD1) by enzyme immunoassay, and the cognitive status by MMSE.

82 easles, mumps, and rubella was measured with enzyme immunoassays, and the avidity of these antibodies

83 seronegative than from the ART-Def group by enzyme immunoassay (ART-96W 49 [46%] of 107 vs ART-Def e

84 gh-disease-burden population in Malawi using enzyme immunoassay as the gold standard diagnostic test.

85 negative Coccidioides serology determined by enzyme immunoassay at presentation.

86 was 74.8% (95% CI, -8.2% to 94.1%) using an enzyme immunoassay-based case definition and 85.1% (95%

87 detected by RNA-based screening coupled with enzyme immunoassay-based testing.

88 eloped an immunoglobulin G (IgG)-capture BED-enzyme immunoassay (BED-CEIA) to identify recent human i

89 Samples were tested with the BED capture enzyme immunoassay (BED-CEIA) which measures the proport

90 HIV incidence that includes the BED capture enzyme immunoassay (BED-CEIA), an antibody avidity assay

91 d a robust MAA that includes the BED capture enzyme immunoassay (BED-CEIA), the Bio-Rad Avidity assay

92 Three enzyme immunoassays, Borrelia DotBlot G (GenBio, San Die

93 matched controls were repeatedly reactive by enzyme immunoassay, but none were confirmed by recombina

94 In addition, new enzyme immunoassays can quantify hepatitis B surface and

95 ed using 3 serologic assays: the BED capture enzyme immunoassay (CEIA), the Bio-Plex (Luminex) assay,

96 clusion, we expect that ODI chemiluminescent enzyme immunoassays (CLEIAs) using a couple of enzymes c

97 and Shiga toxin-producing E. coli (STEC; by enzyme immunoassay), Clostridium difficile (by cytotoxic

98 Enzyme immunoassay detection of anti-HCV antibodies in s

99 Laboratory confirmation was made by enzyme immunoassay detection of rotavirus antigen in sto

100 Enzyme immunoassay determined LTB4, and enzyme-linked im

101 pecimens were strongly rotavirus positive by enzyme immunoassay, displayed VP6 subgroup II specificit

102 m was compared to a Abbott second-generation enzyme immunoassay (EIA 2.0).

103 nc., Buffalo Grove, IL) and compared with an enzyme immunoassay (EIA) (Abbott Laboratories) licensed

104 tive samples were tested for Shiga toxins by enzyme immunoassay (EIA) (ImmunoCard STAT! enterohemorrh

105 specimens, which were also tested for Stx by enzyme immunoassay (EIA) (ProSpecT STEC; Remel, Lenexa,

106 ation for anti-HCV using a second-generation enzyme immunoassay (EIA) and a second-generation qualita

107 immunoglobulin G (IgG) level was measured by enzyme immunoassay (EIA) and by plaque reduction neutral

108 We compared paired enzyme immunoassay (EIA) and latex agglutination (LA) as

109 wo-test algorithm: an initial screen with an enzyme immunoassay (EIA) and reflex testing of EIA-react

110 performance of a human herpesvirus 8 (HHV-8) enzyme immunoassay (EIA) and selective subsequent use of

111 (VLPs) and compared their antigenicities by enzyme immunoassay (EIA) and surrogate antibody neutrali

112 been tested previously with the GP5+/6+ PCR enzyme immunoassay (EIA) and the GP5+/6+ PCR LMNX assay

113 Stool was tested for C. difficile by toxin enzyme immunoassay (EIA) and toxigenic culture (TC).

114 sults by a Campylobacter-specific commercial enzyme immunoassay (EIA) and, less so, a research PCR we

115 tally infected with HEV were tested with one enzyme immunoassay (EIA) based on the Sar-55 antigen and

116 t as an alternative for the more established enzyme immunoassay (EIA) detection of 14 targeted high-r

117 c testing protocol for Lyme disease (LD), an enzyme immunoassay (EIA) followed by immunoglobulin M an

118 The clinical utility of Platelia Aspergillus enzyme immunoassay (EIA) for galactomannan (GM) antigen

119 .e., sorbitol-MacConkey (SMAC) agar culture, enzyme immunoassay (EIA) for Shiga toxin, or the simulta

120 adults vaccinated as children were tested by enzyme immunoassay (EIA) for the presence of vaccinia vi

121 ompared with a less sensitive (LS) (detuned) enzyme immunoassay (EIA) for their abilities to distingu

122 Enzyme immunoassay (EIA) for toxins A/B is too insensiti

123 The commercially-available C6 Lyme enzyme immunoassay (EIA) has been approved to replace th

124 Particle agglutination, dipstick, and enzyme immunoassay (EIA) HBsAg screening detected 54%, 7

125 mon US Food and Drug Administration-approved enzyme immunoassay (EIA) HIV antibody kits were used to

126 inexpensive, commercially available heparin enzyme immunoassay (EIA) kit that has a limit of detecti

127 era were blinded and sent with galactomannan enzyme immunoassay (EIA) kits to the participating labor

128 It has been suggested that enzyme immunoassay (EIA) kits validated in one region ma

129 Antibody detection by enzyme immunoassay (EIA) may increase sensitivity and pe

130 ositive stool tests for toxins A and/or B by enzyme immunoassay (EIA) or tcdB by polymerase chain rea

131 Campylobacter antigen detection by enzyme immunoassay (EIA) provides rapid results compared

132 deleterious implications of a Campylobacter enzyme immunoassay (EIA) result and the increasing impor

133 NN performed quantitative predictions of the enzyme immunoassay (EIA) Signal/Cutoff (S/Co) profiles f

134 pared to results from routine culture and an enzyme immunoassay (EIA) specific for the recovery and i

135 supplanted by the more rapid and inexpensive enzyme immunoassay (EIA) technique.

136 be an unacceptable number of false-positive enzyme immunoassay (EIA) test results for IgM among pers

137 ty, finding 5.5% reactive Treponema pallidum enzyme immunoassay (EIA) tests.

138 d (BDD) electrodes and a competitive magneto-enzyme immunoassay (EIA) that enables high sensitivity.

139 gorithm where the first tier is typically an enzyme immunoassay (EIA) that if positive or equivocal i

140 zes a first-tier immunofluorescence assay or enzyme immunoassay (EIA) that, if the result is positive

141 emergency department, the Directigen Flu A+B enzyme immunoassay (EIA) was performed in the chemistry

142 Serum specimens negative by HIV enzyme immunoassay (EIA) were screened in pools by an ul

143 on by reverse transcriptase PCR (RT-PCR) and enzyme immunoassay (EIA) were similar, but 18% of health

144 We used an amplified enzyme immunoassay (EIA) with a reduced-cutoff "negative

145 we describe a highly sensitive and specific enzyme immunoassay (EIA) with chemically modified, multi

146 TLV-1 and HTLV-2 antibodies were measured by enzyme immunoassay (EIA) with confirmation by immunofluo

147 ng 2 incidence assays, a less-sensitive (LS) enzyme immunoassay (EIA), and the BED assay.

148 assay (ELISA), the Axiom Diagnostics HEV IgG enzyme immunoassay (EIA), and the Mikrogen recomLine HEV

149 a dual glutamate dehydrogenase and toxin A/B enzyme immunoassay (EIA), and the RTCA assay.

150 oplasma galactomannan (GM) in urine using an enzyme immunoassay (EIA), and we showed low positive agr

151 HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptide

152 The methods included enzyme immunoassay (EIA), direct cytotoxin testing, and

153 tration-approved serologic tests, such as an enzyme immunoassay (EIA), followed by Western blot testi

154 )) by Western blotting (WB), antigen capture enzyme immunoassay (EIA), immunohistochemistry (IHC), an

155 en that can be detected in stool by culture, enzyme immunoassay (EIA), or PCR.

156 the SRA and an anti-PF4/heparin IgG-specific enzyme immunoassay (EIA), testing serial serum samples i

157 e sensitive than the widely used solid-phase enzyme immunoassay (EIA), the Premier toxin A and B EIA

158 e dehydrogenase (GDH) assay, a toxin A and B enzyme immunoassay (EIA), the Xpert C. difficile assay,

159 Assays to measure antibody include the enzyme immunoassay (EIA), which measures immunoglobulin

160 ns isolated from Clostridium difficile toxin enzyme immunoassay (EIA)-positive fecal samples from Oxf

161 and the outbreak virus Iowa-G/USA-06 and by enzyme immunoassay (EIA).

162 re tested for mumps immunoglobulin (Ig) G by enzyme immunoassay (EIA).

163 staglandin E2 (PGE2) levels were measured by enzyme immunoassay (EIA).

164 edictive value was 90% compared with 76% for enzyme immunoassay (EIA).

165 standard comparator test (SCT), the GP5+/6+ enzyme immunoassay (EIA).

166 es in titers of antibody to hRSV and hMPV by enzyme immunoassay (EIA).

167 and all results were verified by a standard enzyme immunoassay (EIA).

168 19 years old were tested for EBV antibody by enzyme immunoassay (EIA).

169 Testing was performed using an HEV IgG enzyme immunoassay (EIA, Axiom Diagnostics), and the rec

170 e United States are transitioning from toxin enzyme immunoassays (EIA) to nucleic acid amplification

171 ty assays has been largely replaced by rapid enzyme immunoassays (EIA).

172 ed for the development of antibody detection enzyme immunoassays (EIA).

173 lity is determined primarily by results from enzyme immunoassays (EIA).

174 jirebio Diagnostics, Malvern, PA], Trep-Sure enzyme immunoassay [EIA; Phoenix Biotech, Oakville, Onta

175 equence algorithm; discordant results (e.g., enzyme immunoassay [EIA] reactive and reactive plasma re

176 reactivity of the IDEIA Norovirus assay (an enzyme immunoassay [EIA]) in a prospective and retrospec

177 obe-based species identification system (PCR-enzyme immunoassay [EIA]) was then used to resolve these

178 sponse (by serotonin-release assay [SRA] and enzyme-immunoassay [EIA]), and the frequency of recurren

179 andard, cytotoxicity assay, we studied three enzyme immunoassays (EIAs) and one rapid EIA, which demo

180 d third-generation (G2 and G3, respectively) enzyme immunoassays (EIAs) and to resolve discordant res

181 Currently, culture and enzyme immunoassays (EIAs) are the primary methods used

182 G avidity and epitope type specificity (ETS) enzyme immunoassays (EIAs) for distinguishing past from

183 Recently, several commercially available enzyme immunoassays (EIAs) have been developed for the d

184 om stool specimens and have combined it with enzyme immunoassays (EIAs) in a three-step protocol.

185 We used enzyme immunoassays (EIAs) to measure HHV-8 antibodies (

186 ducted to evaluate the performances of three enzyme immunoassays (EIAs) utilizing one or more conform

187 Enzyme immunoassays (EIAs) were used to measure antibody

188 2007) to correlate physician use of O&P and enzyme immunoassays (EIAs) with the yield of parasites d

189 those of three C. difficile toxin-detecting enzyme immunoassays (EIAs), an EIA for the detection of

190 tested for IgM by both indirect and capture enzyme immunoassays (EIAs), and oral fluids were tested

191 eas HCV-specific antibodies were assessed in enzyme immunoassays (EIAs), chemiluminescent assays, and

192 es for nucleic acid amplification tests, but enzyme immunoassays, even after negative-gray-zone testi

193 ingle-cell migration, immunoblotting, ELISA, enzyme immunoassay), ex vivo (rat aortic ring assay), an

194 characteristic plot showed that autoantibody enzyme immunoassay exhibited 90% sensitivity and 88% spe

195 All discordant cases were retested with an enzyme immunoassay followed by Western blotting, and fiv

196 l stool samples were collected and tested by enzyme immunoassay for Campylobacter Stool and blood sam

197 mpared our two-step diagnostic algorithm, an enzyme immunoassay for glutamate dehydrogenase (GDH) fol

198 etecting toxigenic Clostridium difficile: an enzyme immunoassay for glutamate dehydrogenase antigen (

199 of a commercially available, rapid membrane enzyme immunoassay for influenza A and B virus detection

200 scrapes using a C. trachomatis-specific PCR-enzyme immunoassay for the MOMP-1 gene.

201 m samples from these subjects were tested by enzyme immunoassay for total antibodies to HEV.

202 C. difficile latex agglutination, an enzyme immunoassay for toxins A and B or glutamate dehyd

203 Electrochemiluminescence enzyme immunoassays for 2,4,6-trinitrotoluene (TNT) and

204 Monoclonal antibody-based enzyme immunoassays for Ara h 1, Ara h 2, and Ara h 6 we

205 s has been made with regard to the design of enzyme immunoassays for IFN-gamma, this assay is still l

206 est Nile virus-specific IgM and indirect IgG enzyme immunoassays for the detection of IgG antibodies

207 Recently, immunoglobulin M (IgM)-capture enzyme immunoassays for the detection of West Nile virus

208 fungus-specific primers and DNA probes in an enzyme immunoassay format (PCR-EIA).

209 erologic tests, we evaluated HSV-1 and HSV-2 enzyme immunoassays from Focus Technologies in a longitu

210 reported that the Aspergillus galactomannan enzyme immunoassay (GM EIA) may be a useful diagnostic t

211 red the diagnostic yields of a galactomannan enzyme immunoassay (GM EIA), quantitative real-time PCR

212 evaluated the performance of a galactomannan enzyme immunoassay (GM EIA; Bio-Rad) by using a range of

213 tion available on inclusion of galactomannan enzyme immunoassay (GM-EIA) (2002) and beta-d-glucan (20

214 The galactomannan enzyme immunoassay (GM-EIA) is widely utilized for the d

215 al diagnostics, differences in galactomannan enzyme immunoassay (GM-EIA) performance have been report

216 s B virus (HBV) antibodies and galactomannan enzyme immunoassay (GM-EIA) positivity.

217 Based on BKV-specific IgG enzyme immunoassay >/=8 units, subjects were divided int

218 Initially, the Focus and PANBIO IgM enzyme immunoassays had at least 95% agreement, sensitiv

219 present study developed a novel HCV antigens enzyme immunoassay (HCV-Ags EIA) and assessed its sensit

220 eek 84 using three assays: fourth-generation enzyme immunoassay HIV antigen-antibody combination, HIV

221 oth free and labeled ALP as a Raman probe in enzyme immunoassays, immunoblotting, and DNA hybridizati

222 ulin M and G antibodies were demonstrated by enzyme immunoassay in 8% and 85%, respectively.

223 ent, and detection of rotavirus infection by enzyme immunoassay in at least 100 children <5 years of

224 evels were tested by immunocytochemistry and enzyme immunoassay in BALB/c and B6 corneas.

225 say was more sensitive than the conventional enzyme immunoassay in buffer (IC(50) = 0.1 and 2 microg/

226 prostane as a marker of oxidative stress, by enzyme immunoassay in exhaled breath condensate from pat

227 nce of rotavirus, as determined by Rotaclone enzyme immunoassay, in adults who had stools submitted f

228 chemiluminescent biosensor and conventional enzyme immunoassay indicates that the accurate, precise,

229 The Platelia galactomannan enzyme immunoassay is a commercially available noncultur

230 active treponemal chemiluminescence assay or enzyme immunoassay is low if the epidemiological risk an

231 ercially available affinity purification and enzyme immunoassay kit and found both assays to be in ag

232 The Wampole C. difficile Tox A/B II enzyme immunoassay kit was used.

233 All samples were analyzed with two different enzyme immunoassay kits to gauge assay sensitivity to me

234 utility of SMAC to that of the Premier EHEC enzyme immunoassay (Meridian Diagnostics) for detection

235 ificity and sensitivity of this autoantibody enzyme immunoassay method were compared with the convent

236 Despite the high sensitivity of the enzyme immunoassay method, it is more expensive and has

237 Both DCP and AFP were tested using enzyme immunoassay methods.

238 tly recovered or deceased), serum testing by enzyme immunoassay offers a new and practical diagnostic

239 The MVista anti-Coccidioides antibody enzyme immunoassay offers improved sensitivity, compared

240 r optimizing the sensitivity of an amplified enzyme immunoassay on vulvovaginal-swab specimens.

241 cies were detected by commercially available enzyme immunoassays on stool samples.

242 Moreover, enzyme immunoassays only support a subset of target type

243 Some individuals shed virus detected by enzyme immunoassay or genotyping reverse transcription p

244 value of repeat testing for C. difficile by enzyme immunoassay or PCR.

245 ; 4 specimens were positive for rotavirus by enzyme immunoassay or PCR.

246 l event, with rotavirus detected in stool by enzyme immunoassay or reverse transcription-polymerase c

247 blished infection, as identified by standard enzyme immunoassay or Western blot analysis, appeared in

248 y using comparative metabolomic analysis and enzyme-immunoassay, our results reveal that normal fibro

249 T, or the Premier C. difficile toxin A and B enzyme immunoassay [P-EIA]).

250 ed to those of a colorimetric microtiter PCR enzyme immunoassay (PCR-EIA) used as a diagnostic assay.

251 Adult toxin enzyme immunoassay-positive CDI cases in a population of

252 All C. difficile toxin enzyme-immunoassay-positive and culture-positive samples

253 easures, ward-based contact with symptomatic enzyme-immunoassay-positive patients cannot account for

254 analyzed with SLA/LP-overlapping peptides in enzyme immunoassay, proliferation, and enzyme-linked imm

255 bodies detected by standard serologic tests (enzyme immunoassays, rapid tests, and Western blots) and

256 87 or 2006 strains either reduced or ablated enzyme immunoassay recognition by the GII.4-2002-specifi

257 The samples were analyzed with fluorescence enzyme immunoassays recognizing domestic mite allergens

258 orins, which reflected the rates of use; the enzyme immunoassay replaced the cytotoxin assay because

259 orary techniques, such as immunoblotting and enzyme immunoassays, require extensive sample manipulati

260 els were measured by colorimetric assays and enzyme immunoassay, respectively.

261 quantified by RT-PCR, Western analysis, and enzyme immunoassay, respectively.

262 media were measured with Northern blots and enzyme immunoassays, respectively.

263 d in the testing of >3,000 antigen-positive (enzyme immunoassay) samples collected during clinical tr

264 were compared to those of a third-generation enzyme immunoassay screen with confirmation of repeat re

265 P) examinations, and Giardia/Cryptosporidium enzyme immunoassay screens (GC-EIA) performed for patien

266 Repeat enzyme immunoassay testing for C. difficile toxin has be

267 Sensitive/less sensitive enzyme immunoassay testing is an effective tool for asse

268 , estimated using a sensitive/less sensitive enzyme immunoassay testing strategy.

269 ication of recent infections, less sensitive enzyme immunoassay testing was performed on stored speci

270 g with the increased availability and use of enzyme immunoassay testing, which detects the presence o

271 rithm with repeated sensitive-less-sensitive enzyme immunoassay tests was also evaluated.

272 ed, with the use of sensitive-less-sensitive enzyme immunoassay tests, as recent infections.

273 y nonbronchoscopic bronchoalveolar lavage by enzyme immunoassay, tissue culture, and RT-PCR.

274 tates were tested with the BED HIV-1 capture enzyme immunoassay to classify infections as recent or l

275 a solid phase for developing a sandwich-type enzyme immunoassay to detect C-reactive protein (CRP) us

276 Based on this information, we developed an enzyme immunoassay to detect HHV-8 antibodies in human s

277 TARHS methodology uses the BED HIV-1 capture enzyme immunoassay to determine recent HIV infections by

278 tested their sera using a BED HIV-1 capture enzyme immunoassay to estimate HIV incidence.

279 We used an enzyme immunoassay to measure anti-HEV immunoglobulin G

280 Here, we used enzyme immunoassay to measure fecal glucocorticoid metab

281 ncidence attributable to changing from toxin enzyme immunoassays to NAAT.

282 In the present study, an enzyme immunoassay using viruslike particles (VLPs) was

283 d and confirmed by pull-down experiments and enzyme immunoassays using recombinant LcrH-2 and LcrE.

284 erially during therapy using a microparticle enzyme immunoassay validated with in-house reference sta

285 lates from Japan resulted in a higher median enzyme immunoassay value and slightly fewer samples with

286 An in vitro enzyme immunoassay was established with monoclonal antib

287 The HCV enzyme immunoassay was reported positive in 1590 (12%) p

288 Enzyme immunoassay was used to analyze measles virus-spe

289 A mumps virus-specific enzyme immunoassay was used to measure the seroprevalenc

290 By using enzyme immunoassay, we show uptake of NE, probably throu

291 easures primarily IgG antibodies) and an IgG enzyme immunoassay were found useful for very early diag

292 tes that were tested positive by a Rotaclone enzyme immunoassay were submitted to the Centers for Dis

293 Participants who were positive by HCV enzyme immunoassay were tested for HCV viremia by a bran

294 The INFLU A.B-Quick and Directigen Flu A+B enzyme immunoassays were compared with direct immunofluo

295 at were positive in the Platelia Aspergillus enzyme immunoassay when initially tested.

296 .S. patients and 288 Japanese patients using enzyme immunoassay with different preparations of high-m

297 cation test and a polymer conjugate-enhanced enzyme immunoassay with negative-gray-zone testing.

298 SP-1(19) IgG or IgG subclass Abs measured by enzyme immunoassay with six different recombinant MSP-1(

299 cells expressing lytic viral proteins and by enzyme immunoassays with recombinant viral structural pr

300 -generation Murex HIV Ag/Ab Combination EIA (enzyme immunoassay) within an adolescent and young-adult